In this retrospective study the clinical course and resolution of symptoms of a specific casein-based extensively hydrolysed infant formula in subjects presenting with clinical manifestations of non-IgE-mediated CMPA enteropathies in a paediatric allergy clinic was analysed. This evidence concerns the gene IGHE and Allergy.